Next Generation News and Research

RSS

Scientists to create new drugs with bone formation stimulating activities

A Simon Fraser University researcher is leading a team of scientists working to create new drugs to stimulate bone regeneration - research that will be furthered by a $2.5 million grant from the Canadian Institutes of Health Research (CIHR).

20 Jul 2012

HealthHIV, CCO announce new series of CME/CE-certified interactive local live workshops

Clinical Care Options (CCO), a leader in next-generation medical education, information, and publishing for healthcare professionals, announces a new series of CME/CE-certified interactive local live workshops developed and implemented in partnership with HealthHIV, the leading national HIV nonprofit organization building the capacity of primary care providers to integrate HIV care into their practices.

20 Jul 2012

Single-step method can rapidly detect pathogens and chemical contaminants

Using nanoscale materials, researchers at the University of Georgia have developed a single-step method to rapidly and accurately detect viruses, bacteria and chemical contaminants.

20 Jul 2012

New report compares Gen X attitudes about climate change in 2009 and 2011

As the nation suffers through a summer of record-shattering heat, a University of Michigan report finds that Generation X is lukewarm about climate change-uninformed about the causes and unconcerned about the potential dangers.

19 Jul 2012

New Alzheimer's model derived from skin cells of patients may prove to be more accurate

Researchers at the Alzheimer's Association International Conference 2012 (AAIC 2012) today reported the creation of a new model of Alzheimer's derived from the skin cells of people with the disease that were reprogramed into Alzheimer's brain cells.

17 Jul 2012

Life Technologies acquires Navigenics

Life Technologies Corporation today announced the acquisition of Navigenics, Inc. This acquisition represents Life Technologies' first step in executing against a strategy to build out its molecular diagnostics business through internal development, partnerships and select acquisitions.

17 Jul 2012

Five recent Science and Nature papers shed light on elusive 'GPCRs'

Readers of the top-ranked scientific journals Science and Nature might have noticed a recent wave of articles, most recently in the July 13, 2012 issue of Science, with deep importance for biology and medicine.

14 Jul 2012

amfAR analysis examines impact of potential budget sequestration on global health

In this guest post on the Global Health Technologies Coalition's "Breakthroughs" blog, George Fistonich, a research and policy fellow at amfAR, The Foundation for AIDS Research, examines a new amfAR analysis that "outlines the potential effects of budget sequestration on global health programs, using updated figures to reflect recent and accurate estimates."

14 Jul 2012

Eisai, Verastem partner for next-generation of small molecule Wnt inhibitors

Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced a research collaboration with Eisai for the next-generation of small molecule Wnt inhibitors.

12 Jul 2012

Courtagen launches nucSEEKPDx assay

Courtagen Life Sciences, Inc., a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry, today announced the expansion of their genetic test menu. The new genetic test, nucSEEKPDx, will sequence approximately 1,100 nuclear genes constituting the mitochondrial exome, which encodes the vast majority of proteins found in the mitochondrion. This test is by far the most comprehensive test on the market for the management of mitochondrial disorders.

11 Jul 2012

New approach integrates rational drug design with supramolecular nanochemistry in cancer treatment

Researchers at Brigham and Women's Hospital (BWH) are the first to report a new approach that integrates rational drug design with supramolecular nanochemistry in cancer treatment.

11 Jul 2012

Book explains complex world of personalized medicine

Personalized medicine has promised to radically change the way we look at health and disease. Talk of tailored drug therapies and early detection of cancer has captured the attention of scientists and lay people alike. So when will patients start to reap the benefits of this medical revolution?

11 Jul 2012

New hemoglobin monitoring system for anemia screening introduced by OrSense Ltd.

OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, introduced today at the 32nd International Congress of the International Society of Blood Transfusion (ISBT), in Cancun, Mexico, GlasswingTM, its next-generation, wireless, non-invasive hemoglobin (Hb) measurement system for anemia monitoring, hemorrhage detection and pre-donation screening.

9 Jul 2012

OrSense launches Glasswing for anemia monitoring and hemorrhage detection

OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, introduced today at the 32nd International Congress of the International Society of Blood Transfusion (ISBT), in Cancun, Mexico, Glasswing, its next-generation, wireless, non-invasive hemoglobin (Hb) measurement system for anemia monitoring, hemorrhage detection and pre-donation screening.

9 Jul 2012

ImaCor releases Zura EVO ultrasound system

ImaCor Inc., the pioneer of the world's only hemodynamic transesophageal echocardiography (hTEE) management device, today released the Zura EVO ultrasound system.

9 Jul 2012

Next generation predictive 3D cell toxicity assays to be developed by Medicyte GmbH and Reinnervate Ltd

Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.

9 Jul 2012

MDI and CSIRO ink tech deal for next generation production of 'Green Whistle'

Australian healthcare company Medical Developments International (MDI) and CSIRO have signed a technology deal to develop a new production process for the drug methoxyflurane - the pain-relieving ingredient used in Penthrox™ (commonly known as the green whistle).

9 Jul 2012

UC Riverside receives NSF grant to address water quantity and quality issues

Water is likely to become an even more important factor in determining human well-being in the near future as the world's population continues to increase. While it is clear that the demand for water will steadily rise, it also appears that water supply could decline as a result of major shifts in the world's climate.

8 Jul 2012

UCLA School of Dentistry receives NIH grant to create comprehensive research training program

In recent years, faculty at the UCLA School of Dentistry have been expanding the traditional boundaries of dentistry through groundbreaking multidisciplinary research that has led to major advances in everything from stem cell science to saliva diagnostics. Now, a $5 million grant from the National Institutes of Health's National Institute of Dental and Craniofacial Research will allow the school to continue these pioneering efforts by creating a comprehensive research training program to help cultivate the next generation of dentist-scientists and oral health researchers.

4 Jul 2012

Scientists assemble string of genetic letters that could control parrots' vocal learning

Scientists say they have assembled more completely the string of genetic letters that could control how well parrots learn to imitate their owners and other sounds.

3 Jul 2012

Next Generation News and Research

Scientists to create new drugs with bone formation stimulating activities

HealthHIV, CCO announce new series of CME/CE-certified interactive local live workshops

Single-step method can rapidly detect pathogens and chemical contaminants

New report compares Gen X attitudes about climate change in 2009 and 2011

New Alzheimer's model derived from skin cells of patients may prove to be more accurate

Life Technologies acquires Navigenics

Five recent Science and Nature papers shed light on elusive 'GPCRs'

amfAR analysis examines impact of potential budget sequestration on global health

Eisai, Verastem partner for next-generation of small molecule Wnt inhibitors

Courtagen launches nucSEEKPDx assay

New approach integrates rational drug design with supramolecular nanochemistry in cancer treatment

Book explains complex world of personalized medicine

New hemoglobin monitoring system for anemia screening introduced by OrSense Ltd.

OrSense launches Glasswing for anemia monitoring and hemorrhage detection

ImaCor releases Zura EVO ultrasound system

Next generation predictive 3D cell toxicity assays to be developed by Medicyte GmbH and Reinnervate Ltd

MDI and CSIRO ink tech deal for next generation production of 'Green Whistle'

UC Riverside receives NSF grant to address water quantity and quality issues

UCLA School of Dentistry receives NIH grant to create comprehensive research training program

Scientists assemble string of genetic letters that could control parrots' vocal learning

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News